Symphoniq launches Web app performance tools

Symphoniq on Monday rolled out a set of Web application performance monitoring tools designed to leverage real user experience to track and manage Web-based applications.

The company unveiled its TrueView Web Diagnostics technology, which monitors user transactions rather than using synthetic monitoring data to judge application performance.

The rising complexity of Web applications and their increasingly critical role in organizations are driving the need for a new management approach for Web-based applications, according to Hon Wong, CEO of Symphoniq.

“Current [monitoring] tools only find a quarter of the problem,” Wong said.

Relying on the synthetic approach to managing a Web environment might result in missing the real problems users are encountering, Wong said.

“Monitoring a few static canned pages is not enough. Instead of testing real users running real transactions they just test canned pages. This is an artificial number,” Wong said. “You have to measure the entire spectrum of user experience instead of just measuring average response time.”

TrueView Web Diagnostics measures live transactions at the browser, turning information about those real transactions into actionable data such as user response time, IP address, network latency, infrastructure response time, and the specific servers and machines involved, according to Symphoniq officials.

The offering also correlates client-side and server-side performance data, including page aborts and page rendering problems that are invisible to purely server-side offerings, the company said.

Symphoniq also launched two related products: TrueView Outlook Web Access (OWA) Diagnostics and TrueView J2EE Diagnostics. TrueView  OWA Diagnostics monitors all live OWA transactions to help improve management of OWA performance. TrueView J2EE  Diagnostics monitors the availability to Web-enabled J2EE applications. The first version supports the BEA WebLogic platform and future versions will support IBM WebSphere, JBoss, and others.